Atherectomy Devices Market By Device Type (Directional Atherectomy Devices, Rotational Atherectomy Devices, Orbital Atherectomy Devices, Laser Atherectomy Devices), By Disease Site (Coronary Artery Disease, Peripheral Artery Disease) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

Atherectomy is defined as minimally invasive surgery for the removal of plaque blockages from coronary and peripheral vessels. A perpetual rise in the incidence of arterial blockages, particularly facilitated by the growth in the geriatric population and cardiovascular diseases, majorly contributes to the rise in the number of atherectomy procedures. Due to technological advancements, surgeons are replacing their existing atherectomy devices with novel solutions, as these replacements are found to be more efficient, safe, and come with fewer complications.

The purpose of this research study titled "Atherectomy Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025" is to provide investors, developers, company executives, and industry participants with in-depth analysis to allow them to take strategic initiatives and decisions related to the prospects in the global atherectomy devices market. This report presents and analyses the major trends prevalent in the global atherectomy devices market and provides market size and forecast.

This report categorizes the global atherectomy devices market in terms of device type, disease site, and geographical distribution. Based on device type, the global atherectomy devices market is categorized into directional atherectomy devices, rotational atherectomy devices, orbital atherectomy devices, and laser atherectomy devices. Coronary artery disease and peripheral artery disease are the disease sites considered for the purpose of this study. The market size and forecast for each mentioned segment for the period 2015–2025 are presented in the report, along with respective CAGRs for the forecast duration of 2017–2025.

Geographically, the global atherectomy devices market is best understood by segmenting it into five major regions and five major region-level markets, as follows:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

This study presents the market size and forecast for each considered geographical market for the period 2015-2025, as well as CAGRs for the forecast period 2017-2025, and is further cross-sectionally presented in terms of device type, disease site, and constituent region/country level markets.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global atherectomy devices market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the atherectomy devices market. The key players profiled in this report are Avinger, Inc., Boston Scientific Corporation, Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc. (Volcano Corporation), Straub Medical AG, St. Jude Medical, LLC, and Terumo Interventional Systems.

The global atherectomy devices market is studied for the following device types:

  • Directional atherectomy devices
  • Rotational thrombectomy devices
  • Orbital atherectomy devices
  • Laser atherectomy devices

The high prevalence of peripheral artery diseases worldwide is opening up the market for atherectomy devices. The growing preference for minimally invasive surgeries, which offer advantages such as less blood loss and infection risk, as well as a shorter procedure and recovery period, is also driving the market for atherectomy devices. Among the considered device types, the directional atherectomy devices segment currently dominates the market, followed by rotational devices. Orbital atherectomy systems are a relatively new concept and help treat patients in a more complex stage of the disease. The high revolving speed of these devices assists in a quicker procedure and retains the shape of small tissues while ensuring harmless excretion blockage. Orbital atherectomy devices are used to treat both coronary and peripheral artery diseases.

The global atherectomy devices market is being studied for their application in the following disease sites for the purposes of this study:

  • Coronary Artery Disease
  • Peripheral Artery Disease

Between the considered disease sites, peripheral artery diseases capture the largest revenue share in the global atherectomy devices market. The clinical term "peripheral artery disease" is used for classifying occlusive or stenotic lesions due to thromboembolic or atherosclerotic disease. Patients with peripheral arterial disease often require invasive procedures to alleviate blockage and slow disease progression. Percutaneous transluminal angioplasty and balloon angioplasty are conventionally used for treating focal lesions. However, the risk of recoil and the lack of sufficient patency rates for long lesions limit the demand for these procedures. In addition, the presence of rigid calcifications may also lead to incomplete or partial stent expansion and residual stenosis.

As a result, the lack of therapies for restenosis has prompted the search for alternative treatments, such as plaque modification with atherectomy. Directional atherectomy is most commonly used for treating peripheral artery disease. These devices use carbide-tipped rotating cutters that resect and remove plaque. These devices have a proven advantage in reducing the risk of barotrauma and, thus, reducing the risk of dissection and neointimal hyperplasia. However, distal embolization is a major concern with directional devices, and the need for the use of distal protection devices is also felt in cases of heavily calcified lesions.

Geographically, the global atherectomy devices market is cumulative for North America, Europe, Asia Pacific, the Middle East, Africa, and Latin America.

Among the considered regional markets, North America and Europe together occupy the largest revenue share of the global atherectomy devices market. In North America and globally, the United States captures the largest revenue share. Higher prevalence of coronary and peripheral artery diseases, better awareness among the patient population and physicians, and an evolving reimbursement scenario are the key factors driving the North American and European markets. Furthermore, the residence of major market players, ensuring an early bird advantage, facilitates market growth in these regions. Furthermore, Asia Pacific is anticipated to be the fastest-growing regional market for atherectomy devices. Growing awareness, the rapid development of healthcare infrastructure, and perpetual growth in the prevalence of lifestyle-related diseases and obesity are the main driving factors for the Asia Pacific atherectomy devices market.

The detailed regional classification of the global atherectomy devices market is as follows:

  • North America (U.S. and Canada)
  • Europe (U.K., Germany, and the Rest of Europe)
  • Asia Pacific (China, Japan, and the Rest of Asia Pacific)
  • Latin America (Brazil, Mexico, and the Rest of Latin America)
  • Middle East and Africa (GCC plus the rest of the Middle East and Africa) 

Frequently Asked Questions:

The market for Atherectomy Devices Market is expected to reach US$ 3,568.1 Mn By 2025.

The Atherectomy Devices Market is expected to see significant CAGR growth over the coming years, at 6.13%.

The report is forecasted from 2017-2025.

The base year of this report is 2016.

Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Cardiovascular Systems, Inc., Spectranetics, Philips Holding USA, Inc. (Volcano Corporation), Straub Medical AG, St. Jude Medical, LLC are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Sep 2017
Category:  Medical Devices
Report ID:   58660
Report Format:   PDF
Pages:   120
Rating:    4.5 (80)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support